Hepatitis C Virus NS 5 A Activates the Mammalian Target of Rapamycin ( mTOR )

Lu Peng,Dongyu Liang,Wenyan Tong,Jianhua Li,Zhenghong Yuan
2010-01-01
Abstract:Hepatitis C virus (HCV) often establishes a persistent infection thatmost likely involves a complex host-virus interplay.We previously reported that the HCV nonstructural protein 5A (NS5A) bound to cellular protein FKBP38 and resulted in apoptosis suppression in human hepatoma cell line Huh7. In the present researchwe further found thatNS5A increasedphosphorylation levels of twomTOR-targeted substrates, S6K1and4EBP1, inHuh7 in the absence of serum.mTOR inhibitor rapamycin orNS5Aknockdown blocked S6K1 and 4EBP1 phosphorylation increase in NS5A-Huh7 andHCV replicon cells, suggesting thatNS5A specifically regulated mTOR activation. Overexpression of NS5A and FKBP38mutantsorFKBP38knockdownrevealed thismTORactivation was dependent on NS5A-FKBP38 interaction. Phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 treatment in NS5A-Huh7showedthat themTORactivationwas independentof PI3K. Moreover, NS5A suppressed caspase 3 and poly(ADP-ribose)polymerase activation,whichwasabolishedbyNS5Aknockdownor rapamycin, indicatingNS5A inhibited apoptosis specifically through the mTOR pathway. Further analyses suggested that apoptotic inhibition exerted by NS5A via mTOR also required NS5A-FKBP38 interaction. Glutathione S-transferase pulldown and co-immunoprecipitation showed that NS5A disrupted the mTOR-FKBP38 association. Additionally, NS5A or FKBP38 mutants recovered the mTOR-FKBP38 interaction; this indicated that the impairment of mTOR-FKBP38 associationwas dependent onNS5A-FKBP38binding. Collectively, our data demonstrate that HCVNS5A activates themTOR pathway to inhibit apoptosis through impairing the interaction between mTOR and FKBP38, which may represent a pivotal mechanism for HCV persistence and pathogenesis.
What problem does this paper attempt to address?